Inhibition of DNA methylation increases follistatin expression and secretion in the human adrenocortical cell line NCI-H295R

Journal of Endocrinology

Volumn 188, Issue 2, 2006, Pages 305-310

  Utrianen, Pauliina ^a   Liu, Jianqi ^b   Kuulasmaa, Tiina ^a   Voutilainen, Raimo ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ACTIVIN; FOLLISTATIN; GENOMIC DNA; MESSENGER RNA;

ADRENAL CORTEX CELL; ADRENAL CORTEX TUMOR; APOPTOSIS; ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DNA METHYLATION; DNA SYNTHESIS INHIBITION; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEROIDOGENESIS;

ADRENAL CORTEX; AZACITIDINE; CELL LINE; DNA METHYLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FOLLISTATIN; GENE EXPRESSION REGULATION; HUMANS; PEPTIDES; PROTEIN ISOFORMS; RNA, MESSENGER;

EID: 33244475108     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06392     Document Type: Article

References (25)

1. Arola J, Liu J, Heikkilä P, Ilvesmäki V, Salmenkivi K, Voutilainen R & Kahri AI 2000 Expression of inhibin α in adrenocortical tumours reflects the hormonal status of the neoplasm. Journal of Endocrinology 165 223-229.
2. de Winter JP, ten Dijke P, de Vries CJ, van Achterberg TA, Sugino H, de Waele P, Huylebroeck D, Verschueren K & van den Eijnden-van Raaij AJ 1996 Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors. Molecular and Cellular Endocrinology 116 105-114.
3. Gao Z, Suppola S, Liu J, Heikkilä P, Jänne J & Voutilainen R 2002 Association of H19 promoter methylation with the expression of H19 and IGF-II genes in adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 87 1170-1176.
4. Guo Q, Kumar TR, Woodruff TK, Hadsell LA, DeMayo FJ & Matzuk MM 1998 Overexpression of mouse follistatin causes reproductive defects in transgenic mice. Molecular Endocrinology 12 96-106.
5. Ilvesmäki V, Kahri AI, Miettinen PJ & Voutilainen R 1993 Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas. Journal of Clinical Endocrinology and Metabolism 77 852-858.
6. Liang G, Gonzales FA, Jones PA, Orntoft TF & Thykjaer T 2002 Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2′-deoxycytidine. Cancer Research 62 961-966.
7. Liu J, Kahri AI, Heikkilä P, Blum WF & Voutilainen R 1994 Glucocorticoids increase insulin-like growth factor-II mRNA accumulation in cultured human phaeochromocytoma cells. Journal of Endocrinology 142 29-35.
8. Liu J, Kahri AI, Heikkilä P, Ilvesmäki V & Voutilainen R 1995 H19 and insulin-like growth factor-II gene expression in adrenal tumors and cultured adrenal cells. Journal of Clinical Endocrinology and Metabolism 80 492-496.
9. Liu J, Heikkilä P, Kahri AI & Voutilainen R 1996 Expression of the steroidogenic acute regulatory protein mRNA in adrenal tumors and cultured adrenal cells. Journal of Endocrinology 150 43-50.
10. Liu J, Voutilainen R, Kahri AI & Heikkilä P 1997 Expression patterns of the c-myc gene in adrenocortical tumors and pheochromocytomas. Journal of Endocrinology 152 175-181.
11. Liu J, Li X-D, Vaheri A & Voutilainen R 2004 DNA methylation affects cell proliferation, cortisol secretion and steroidogenic gene expression in human adrenocortical NCI-H295R cells. Journal of Molecular Endocrinology 33 651-662.
12. Matzuk MM, Lu N, Vogel H, Sellheyer K, Roop DR & Bradley A 1995 Multiple defects and perinatal death in mice deficient in follistatin. Nature 374 360-363.
13. Munro LMA, Kennedy A & McNicol AM 1999 The expression of inhibin/activin subunits in the human adrenal cortex and its tumours. Journal of Endocrinology 161 341-347.
14. Nakamura T, Sugino K, Titani K & Sugino H 1991 Follistatin, an activin-binding protein, associates with heparan sulfate chains of proteoglycans on follicular granulosa cells. Journal of Biological Chemistry 266 19432-19437.
15. Phillips DJ & de Kretser DM 1998 Follistatin: a multifunctional regulatory protein. Frontiers in Neuroendocrinology 19 287-322.
16. Sidis Y, Schneyer AL & Keutmann HT 2005 Heparin and activin-binding determinants in follistatin and FSTL3. Endocrinology 146 130-136.
17. Singer-Sam J, Grant M, LeBon JM, Okuyama K, Chapman V, Mong M & Riggs AD 1990 Use of a HpaII-polymerase chain reaction assay to study DNA methylation in the Pgk-1 CpG island of mouse embryos at the time of X-chromosome inactivation. Molecular and Cellular Biology 10 4987-4989.
18. Schneyer AL, Wang Q, Sidis Y & Sluss PM 2004 Differential distribution of follistatin isoforms: application of a new FS315-specific immunoassay. Journal of Clinical Endocrinology and Metabolism 89 5067-5075.
19. Spencer SJ, Mesiano S, Lee JY & Jaffe RB 1999 Proliferation and apoptosis in the human adrenal cortex during the fetal and perinatal periods: implications for growth and remodeling. Journal of Clinical Endocrinology and Metabolism 84 1110-1115.
20. Suzuki J, Otsuka F, Inagaki K, Takeda M, Ogura T & Makino H 2004 Novel action of activin and bone morphogenetic protein in regulating aldosterone production by human adrenocortical cells. Endocrinology 145 639-649.
21. Szyf M, Milstone DS, Schimmer BP, Parker KL & Seidman JG 1990 Cis modification of the steroid 21-hydroxylase gene prevents its expression in the Y1 mouse adrenocortical tumor cell line. Molecular Endocrinology 4 1144-1152.
22. Vänttinen T, Kuulasmaa T, Liu J & Voutilainen R 2002 Expression of activin/inhibin receptor and binding protein genes and regulation of activin/inhibin peptide secretion in human adrenocortical cells. Journal of Clinical Endocrinology and Metabolism 87 4257-4263.
23. Vänttinen T, Liu J, Kuulasmaa T, Kivinen P & Voutilainen R 2003 Expression of activin/inhibin signaling components in the human adrenal gland and the effects of activins and inhibins on adrenocortical steroidogenesis and apoptosis. Journal of Endocrinology 178 479-489.
24. Wade PA 2001 Methyl CpG-binding proteins and transcriptional repression. Bioessays 23 1131-1137.
25. Wang EY, Ma EY & Woodruff TK 2003 Activin signal transduction in the fetal rat adrenal gland and in human H295R cells. Journal of Endocrinology 178 137-148.